打铁不如李铁
01-30
$同源康医药-B(02410)$
公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(药品审评中心CDE)纳入优先审评品种名单
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":527140748206600,"tweetId":"527140748206600","gmtCreate":1769745337706,"gmtModify":1769745340104,"author":{"id":4193625296607780,"idStr":"4193625296607780","authorId":4193625296607780,"authorIdStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(药品审评中心CDE)纳入优先审评品种名单</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(药品审评中心CDE)纳入优先审评品种名单</p></body></html>","text":"$同源康医药-B(02410)$ 公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(药品审评中心CDE)纳入优先审评品种名单","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/527140748206600","repostId":0,"isVote":1,"tweetType":1,"viewCount":163,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":120,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/527140748206600"}
精彩评论